Gestational Surrogacy in India: Laws, Eligibility, and Alternatives for Foreign Couples in 2026
Gestational Surrogacy in India: Laws, Eligibility, and Alternatives for Foreign Couples in 2026
India was once one of the world's most popular destinations for international surrogacy. Between 2002 and 2015, thousands of foreign couples — from Nigeria, Kenya, the USA, UK, Australia, and across Europe — travelled to India to have children through gestational surrogacy at a fraction of the cost charged in Western countries. That era ended with progressive regulatory changes culminating in the Surrogacy (Regulation) Act 2021, which fundamentally changed who can access surrogacy in India.
This guide explains the current legal position clearly, addresses common misconceptions that continue to circulate online, and outlines the fertility treatment options that remain available to international patients in India.
TL;DR: Surrogacy in India is now restricted to Indian married couples only. Foreign nationals, NRIs, and PIOs are not eligible under the Surrogacy (Regulation) Act 2021. However, India remains a leading destination for IVF, donor egg programmes, and other fertility treatments that are fully legal and available to international patients at 60–80% less than Western prices.
The Current Legal Position: Surrogacy (Regulation) Act 2021
The Surrogacy (Regulation) Act 2021 came into effect on 25 January 2022 and is the governing legislation for all surrogacy arrangements in India. Here are the key provisions that affect international patients:
Who is eligible for surrogacy in India:
- Indian married couples where the wife is aged 23–50 and the husband is aged 26–55
- The couple must have a medical certificate of infertility from a district medical board
- Only altruistic surrogacy is permitted — no payment to the surrogate beyond medical expenses and insurance
Who is NOT eligible:
- Foreign nationals (citizens of any country other than India)
- Non-Resident Indians (NRIs)
- Persons of Indian Origin (PIOs) and Overseas Citizens of India (OCI)
- Single individuals (Indian or foreign)
- Same-sex couples
- Live-in partners (unmarried couples)
Commercial surrogacy is completely banned. No clinic, hospital, or individual in India can legally arrange surrogacy for compensation beyond medical expenses. Any entity offering commercial surrogacy or surrogacy for foreign nationals is operating outside the law.
Common Misconceptions
Despite the law being in effect since 2022, several misconceptions continue to appear in online forums and are worth addressing directly.
"I can still arrange surrogacy in India through an agent." Any agent or clinic offering surrogacy to foreign nationals is operating illegally. The penalties under the Act include imprisonment up to 10 years and fines up to INR 10 lakh (approximately $12,000). Engaging with such arrangements puts both the intended parents and the surrogate at serious legal risk, including potential issues with the child's citizenship and birth registration.
"If I have Indian heritage or an OCI card, I qualify." No. The Act specifically excludes NRIs, PIOs, and OCI cardholders. Only Indian citizens residing in India are eligible.
"The law might change soon." While laws can always be amended, as of March 2026 there are no pending legislative proposals to reopen surrogacy to foreign nationals. The regulatory direction has been consistently toward stricter oversight, not liberalisation.
"I can do surrogacy in India and register the birth in my home country." Even if an illegal arrangement were attempted, most countries — including Nigeria, Kenya, Ghana, and Uganda — do not have straightforward legal pathways for recognising a child born through surrogacy abroad. This creates severe citizenship and immigration complications that can leave a child stateless.
Why India Restricted Surrogacy for Foreigners
Understanding the reasoning behind the legislation provides important context. India's commercial surrogacy industry grew rapidly from the early 2000s, reaching an estimated $2.3 billion by 2015. However, this growth came with documented concerns:
- Exploitation of surrogate mothers: Many surrogates were economically vulnerable women from rural areas who had limited understanding of the medical risks and legal implications of surrogacy contracts.
- Inadequate legal protections: There was no comprehensive regulatory framework protecting surrogates' health, consent, or post-delivery welfare.
- Citizenship complications: Children born to foreign parents through Indian surrogates faced complex nationality issues. Several high-profile cases involved children effectively stranded in India while citizenship disputes were resolved.
- Commodification concerns: The framing of surrogacy as a commercial transaction raised ethical questions about the commodification of women's reproductive capacity.
The 2021 Act was the legislative response to these concerns, prioritising protection of surrogate mothers over market access.
Fertility Treatments Available to International Patients
While surrogacy is off the table, India remains one of the most cost-effective and clinically advanced destinations for other fertility treatments. These are fully legal and available to international patients:
IVF (In Vitro Fertilisation)
IVF is widely available across India at both large hospital-based fertility centres and standalone IVF clinics. India has over 1,500 IVF centres, with top-tier clinics achieving success rates of 45–55% per cycle for women under 35.
Cost: $2,500–5,000 per cycle (compared to $15,000–25,000 in the USA). For a detailed cost breakdown, see our IVF cost guide for international patients.
Donor Egg IVF
For women with diminished ovarian reserve or genetic conditions, donor egg IVF is a well-established option. Indian clinics maintain anonymous donor egg banks with thorough screening protocols regulated under the Assisted Reproductive Technology (Regulation) Act 2021.
Cost: $3,500–6,000 per cycle.
IUI (Intrauterine Insemination)
A less invasive and more affordable first-line fertility treatment.
Cost: $300–800 per cycle.
Embryo Freezing and Fertility Preservation
International patients can undergo ovarian stimulation and egg retrieval in India, with embryos or eggs frozen for future use.
Cost: $1,500–3,000 for retrieval and initial freezing, plus $200–400 per year for storage.
Fertility Assessment and Second Opinions
Many international patients travel to India specifically for comprehensive fertility workups — hormonal panels, ultrasound evaluation, hysteroscopy, semen analysis — at a fraction of the cost in their home country. Results and treatment recommendations can then guide decisions about where to pursue treatment.
Countries Where Surrogacy Remains an Option
For international patients who specifically need surrogacy, the following countries have legal frameworks that permit it for foreign nationals (laws vary and change — independent legal advice is essential):
- United States (certain states including California, Connecticut, Nevada): Gestational surrogacy legal for all intended parents. Cost: $80,000–150,000.
- Ukraine: Gestational surrogacy available for married heterosexual couples. Cost: $30,000–50,000.
- Georgia: Available for heterosexual couples. Cost: $35,000–50,000.
- Colombia: Legal framework developing. Cost: $40,000–60,000.
These options involve significantly higher costs than Indian surrogacy once did, which is partly why misconceptions about Indian surrogacy availability persist.
Next Steps for International Fertility Patients
If you are considering fertility treatment in India, the process starts with sharing your medical history and previous fertility records for review by an Indian fertility specialist. Many clinics offer remote consultations as a first step, allowing you to receive a treatment plan and cost estimate before committing to travel.
India's fertility treatment infrastructure — experienced reproductive endocrinologists, modern embryology laboratories, and internationally accredited clinics — remains fully accessible to international patients. The restriction applies only to surrogacy, not to the broader range of assisted reproduction technologies that help thousands of international patients each year.
